Bio-Rad Laboratories, Inc. (BIO)

NYQ – Real Time Price. Currency in USD

352.23

-4.02 (-1.13%)

Market open: Aug 12, 2026, 10:17 AM EDT

356.25

0.00 (0.00%)

Previous after-hours: Aug 11, 2026, 7:34 PM EDT

10.08.2026

Don't Overlook Bio-Rad (BIO) International Revenue Trends While Assessing the Stock

Explore Bio-Rad's (BIO) international revenue trends and how these numbers impact Wall Street's forecasts and what's ahead for the stock.

05.08.2026

Bio-Rad Laboratories Q2 Earnings Call Highlights

Bio-Rad Laboratories NYSE: BIO reported second-quarter revenue of approximately $651 million, essentially flat from $652 million a year earlier on a reported basis and down 1.9% on a currency-neutral basis, as continued softness in academic research markets weighed on its Life Science segment.

05.08.2026

Bio-Rad Laboratories, Inc. (BIO) Q2 2026 Earnings Call Transcript

05.08.2026

Bio-Rad Laboratories (BIO) Beats Q2 Earnings Estimates

Bio-Rad Laboratories (BIO) came out with quarterly earnings of $2.62 per share, beating the Zacks Consensus Estimate of $2.34 per share. This compares to earnings of $2.61 per share a year ago.

04.08.2026

Bio-Rad Reports Second-Quarter 2026 Financial Results

HERCULES, Calif.--(BUSINESS WIRE)--Bio-Rad Laboratories, Inc. (NYSE: BIO and BIO.B), a global leader in life science research and clinical diagnostics products, today announced financial results for the second quarter ended June 30, 2026. Norman Schwartz, Bio-Rad's Chairman and Chief Executive Officer, stated: “Second-quarter reported revenue was flat year-over-year, with growth in Clinical Diagnostics offset by continued softness in Life Science. Despite Life Science headwinds, our digital PCR.

Videos

No Data

There is no data to display

Press releases

04.08.2026

Bio-Rad Laboratories, Inc. (BIO)

Get all premium features to the best stock analysis tool

Finranks

Company

Contact us

Follow us

Bio-Rad Laboratories, Inc. (BIO)

Don't Overlook Bio-Rad (BIO) International Revenue Trends While Assessing the Stock

Bio-Rad Laboratories Q2 Earnings Call Highlights

Bio-Rad Laboratories, Inc. (BIO) Q2 2026 Earnings Call Transcript

Bio-Rad Laboratories (BIO) Beats Q2 Earnings Estimates

Bio-Rad Reports Second-Quarter 2026 Financial Results

Videos

No Data

Press releases

Bio-Rad Reports Second-Quarter 2026 Financial Results

Don't Overlook Bio-Rad (BIO) International Revenue Trends While Assessing the Stock

Bio-Rad Laboratories Q2 Earnings Call Highlights

Bio-Rad Laboratories, Inc. (BIO) Q2 2026 Earnings Call Transcript

Bio-Rad Laboratories (BIO) Beats Q2 Earnings Estimates

Bio-Rad Reports Second-Quarter 2026 Financial Results

Videos

No Data

Press releases

Bio-Rad Reports Second-Quarter 2026 Financial Results

Search stocks

Bio-Rad Laboratories, Inc. (BIO)

Get all premium features to the best stock analysis tool

Finranks

Company

Contact us

Follow us

Bio-Rad Laboratories, Inc. (BIO)

Don't Overlook Bio-Rad (BIO) International Revenue Trends While Assessing the Stock

Bio-Rad Laboratories Q2 Earnings Call Highlights

Bio-Rad Laboratories, Inc. (BIO) Q2 2026 Earnings Call Transcript

Bio-Rad Laboratories (BIO) Beats Q2 Earnings Estimates

Bio-Rad Reports Second-Quarter 2026 Financial Results

Videos

No Data

Press releases

Bio-Rad Reports Second-Quarter 2026 Financial Results

Don't Overlook Bio-Rad (BIO) International Revenue Trends While Assessing the Stock

Bio-Rad Laboratories Q2 Earnings Call Highlights

Bio-Rad Laboratories, Inc. (BIO) Q2 2026 Earnings Call Transcript

Bio-Rad Laboratories (BIO) Beats Q2 Earnings Estimates

Bio-Rad Reports Second-Quarter 2026 Financial Results

Videos

No Data

Press releases

Bio-Rad Reports Second-Quarter 2026 Financial Results